Benzinga | Feb 22, 2021 04:09PM EST

ImmuCell Q4 EPS $0.03 Up From $(0.04) YoY, Sales $3.74M Miss $4.00M Estimate

ImmuCell (NASDAQ:ICCC) reported quarterly earnings of $0.03 per share. This is a 175 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $3.74 million which missed the analyst consensus estimate of $4.00 million by 6.43 percent. This is a 3.06 percent increase over sales of $3.63 million the same period last year.